Overview

Dexmedetomidine Pharmacokinetics During Continuous Renal Replacement Therapy (CRRT)

Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine dexmedetomidine pharmacokinetics during continuous renal replacement therapy on critically ill patients.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Helsinki University Central Hospital
Treatments:
Dexmedetomidine